Researchers say if Crohn's disease patients still experience recurring symptoms despite undergoing anti-tumor necrosis factor therapy, physicians should not automatically presume that treatment regimen has failed, according to an Internal Medicine News report.
Before changing the therapy regimen, researchers from the Mayo Clinic and UCSD said physicians should reassess the patient to determine whether the recurring symptoms are a results of Crohn's disease or perhaps some other condition, such as enteric infection, concomitant IBS or depression.
They also suggest conducting CT or MR enterography before changing the treatment. If employing capsule endoscopy, physicians should be mindful of potential small-bowel obstruction that would require surgery, they said.
Read the news report about reassessing anti-TNF therapy for Crohn's disease patients.
Read other coverage about GI studies:
- Diet Impacts Occurrence of Inflammatory Bowel Disease
- Johns Hopkins: Pediatric IBD Cases Growing, but Diagnosed Late
- Study: Patients Taking Isotretinoin at Increased Risk of Ulcerative Colitis
Before changing the therapy regimen, researchers from the Mayo Clinic and UCSD said physicians should reassess the patient to determine whether the recurring symptoms are a results of Crohn's disease or perhaps some other condition, such as enteric infection, concomitant IBS or depression.
They also suggest conducting CT or MR enterography before changing the treatment. If employing capsule endoscopy, physicians should be mindful of potential small-bowel obstruction that would require surgery, they said.
Read the news report about reassessing anti-TNF therapy for Crohn's disease patients.
Read other coverage about GI studies:
- Diet Impacts Occurrence of Inflammatory Bowel Disease
- Johns Hopkins: Pediatric IBD Cases Growing, but Diagnosed Late
- Study: Patients Taking Isotretinoin at Increased Risk of Ulcerative Colitis